About the iwNHL Meeting

About the iwNHL meeting

We’re excited to announce that the 19th iwNHL Workshop will take place in person in Barcelona, Spain, on 9 – 11 September, 2022, where the world’s leading clinical researchers in non-Hodgkin lymphoma will share their perspectives on how to place this evolving understanding in a clinical context and thereby optimize clinical care.

In keeping with the ethos of iwNHL, the emphasis of the workshop will be on short presentations, sessions of live interactive debate and panel discussions. Each day will showcase stimulating and insightful content.

As a consequence of the COVID-19 Pandemic and the success of the 2021 virtual workshops, the Scientific Committee and Organisers have decided that the format for the 2022 meeting will be a hybrid workshop, with faculty/attendees meeting in a face-to-face workshop environment, with the opportunity for an expanded faculty and attendees joining virtually by invitation only.

The post-ASH 2021 iwNHL Virtual Workshop took place on 27 – 28 January, 2022, and focused on key updates in non-Hodgkin lymphoma from the 63rd ASH Annual Meeting & Exposition. Click here to view the presentations & discussions.

iwNHL is an annual workshop/think-tank bringing together leading international clinical and translational research minds in non-Hodgkin lymphoma together in an in-person forum to discuss the current state of affairs in clinical care and research in non-Hodgkin lymphoma and to set the agenda for clinical and translational research priorities in collaboration with relevant stakeholders. Objectives are:
– Create annual opportunity for exchange of free flow of ideas, knowledge, and research in non-Hodgkin lymphoma

– Enhance networking and inter-disciplinary collaborations

– Create a platform for a united voice from non-Hodgkin lymphoma scientific/research community to provide focused input into the research priorities

– Improve clinical trial design and conduct to be more efficient and inclusive through robust interactions with industry sponsors, regulators, and patient advocacy groups

– Create an non-Hodgkin lymphoma-focused research agenda for philanthropic/funding agencies

Our Media Partner

We’re pleased to have the Video Journal of Hematological Oncology (VJHemOnc) be our official media partner, providing on-demand coverage that can be viewed in the Meeting Highlights tab.

VJHemOnc is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers.

The goal of the journal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals, worldwide, on a range of innovative digital media – including video and blog formats.

VJHemOnc content is led by an editorial board of highly respected thought leaders with a combined expertise that spans the spectrum of hematological cancers. All content is created and published under the guidance of this board of world-leading experts.

For more information please see www.VJHemOnc.com

© 2014 - 2022 World Health Communications Ltd